CPA Applauds President Trumpās Executive Order to Restore U.S. Pharmaceutical Manufacturing
President Trump’s Executive Order is a bold, necessary move to rebuild Americaās pharmaceutical industry and protect our citizens.
President Trump’s Executive Order is a bold, necessary move to rebuild Americaās pharmaceutical industry and protect our citizens.
Tariffs on pharmaceutical companies isnāt just good economic policy ā it benefits national security and public health.
The National Institutes of Health (NIH) is today the main source of new drugs in this country ā indeed the world, because America leads in the field. It has a critical importance to Americaās health. Less well known is its huge, positive, economic impact.
Itās been five years in the making, yet a bill requiring online retailers to label the country of origin for merchandise remains a tough sell in Congressāeven among the lawmakers who introduced it back in 2020.
Itās been a rough start to 2025 for Indian pharmaceutical giants. Four of Indiaās biggest generic drug producers issued product recalls in the last three months.
In 2024, China and India accounted for 57.6% of total U.S. pharmaceutical imports by weight, highlighting the potential risks associated with such reliance. Growing U.S. dependence on China and India for widely-used generic pharmaceutical products creates serious risks to national security and patient safety when drugs are in short supply, or ineffective.
For far too long, America has been at the mercy of foreign producers that routinely violate FDA safety regulations for life-saving medicines, generic drugs, and essential medical equipment.
Food imports into the U.S. are on the rise. The trend now is for agricultural commodity trade deficits, rather than surpluses, with key commodities like beef usually in a deficit. Despite the increase in food imports, the Food and Drug Administration conducted far fewer than the annual goal of 19,200 inspections, according to FDA data.
De minimis, a customs rule that allows for duty free shipment and minimal inspection if the overseas vendor claims the value is under $800, is a haven for contraband, whether itās fake Nikes, childrensā toys made of lead, or banned food products, Customs and Border Protect (CBP) admitted yet again.
Commerce Secretary Gina Raimondo was asked to impose anti-dumping and countervailing duties (AD/CVD) on Southeast Asian solar companies in a letter from the United Steelworkers Union (USW) on Aug. 27.